Efficacy and safety of indacaterol/glycopyrronium in Japanese patients with COPD: a subgroup analysis from the SHINE study [Corrigendum]

Efficacy and safety of indacaterol/glycopyrronium in Japanese patients with COPD: a subgroup analysis from the SHINE study [Corrigendum]

Blog Article

Hashimoto S, Ikeuchi H, Murata S, Car Sunshade Kitawaki T, Ikeda K, Banerji D.Int J Chron Obstruct Pulmon Dis.2016;11:2543–2551.

 On page 2547, Figure 5, x-axis, the dose mentioned in the label for IND should have read “150 μg od” instead of “110 μg od” and the dose for GLY should have ORG RELIEFIBRE POWDER TROPIC read “50 μg od” instead of “110 μg od”.Read the original article here. .